Richard Ogunti
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Richard Ogunti has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Hilda Mariana Gonzalez Bonilla
Department of Cardiovascular Medicine, Mayo Clinic Rochester, Rochester, MN, USA
1 shared publication Isaac Opoku-Asare
Howard University Hospital, Washington, DC, USA
1 shared publication- James J. Mancuso
The University of Texas MD Anderson Cancer Center 4 Department of Immunology Houston, Texas
1 shared publication - Jenny C. Chang
Houston Methodist Cancer Center, Houston, TX, USA
1 shared publication - Julius S. Ngwa
Developing Brain Institute, Children’s National Hospital, Washington, DC 20010, USA
1 shared publication - Mamta Puppala
T.T. & W.F. Chao Center for BRAIN Houston Methodist Academic Institute Houston Methodist Hospital Houston Texas USA
1 shared publication
Latest Publications
- 1 January 2017
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 365-368
Deep learning analytics for diagnostic support of breast cancer disease management
Breast cancer continues to be one of the leading causes of cancer death among women. Mammogram is the standard of care for screening and diagnosis of breast cancer. The American College of Radiology developed the Breast Imaging Reporting and Data System (BI-RADS) lexicon to standardize mammographic reporting to assess cancer risk and facilitate biopsy decision-making. However, because substantial inter-observer variability remains in the application of the BI-RADS lexicon, including inappropriate term usage and missing data, current biopsy decision-making accuracy using the unstructured free text or semi-structured reports varies greatly. Hence, incorporating novel and accurate technique into breast cancer decision-making data is critical. Here, we combined natural language processing and deep learning methods to develop an analytic model that targets well-characterized and defined specific breast suspicious patient subgroups rather than a broad heterogeneous group for diagnostic support of breast cancer management.
- 1 January 2017
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 365-368
Deep learning analytics for diagnostic support of breast cancer disease management
Breast cancer continues to be one of the leading causes of cancer death among women. Mammogram is the standard of care for screening and diagnosis of breast cancer. The American College of Radiology developed the Breast Imaging Reporting and Data System (BI-RADS) lexicon to standardize mammographic reporting to assess cancer risk and facilitate biopsy decision-making. However, because substantial inter-observer variability remains in the application of the BI-RADS lexicon, including inappropriate term usage and missing data, current biopsy decision-making accuracy using the unstructured free text or semi-structured reports varies greatly. Hence, incorporating novel and accurate technique into breast cancer decision-making data is critical. Here, we combined natural language processing and deep learning methods to develop an analytic model that targets well-characterized and defined specific breast suspicious patient subgroups rather than a broad heterogeneous group for diagnostic support of breast cancer management.